Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Inebilizumab"'
Publikováno v:
International Journal of Ophthalmology, Vol 17, Iss 6, Pp 1073-1078 (2024)
AIM: To investigate the short-term efficacy and safety of inebilizumab for neuromyelitis optica spectrum disorders (NMOSD). METHODS: A total of 33 patients with NMOSD treated with inebilizumab (Group INB, n=15) or rituximab (Group RTX, n=18) in addit
Externí odkaz:
https://doaj.org/article/330b4d10b1834d28bfaa61ad929e9f49
Autor:
Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey C. Yu, Jeroen Jansen, Ina Zhang
Publikováno v:
Neurology and Therapy, Vol 13, Iss 3, Pp 535-549 (2024)
Abstract Introduction Anti-aquaporin-4 antibody-positive (AQP4-Ab+) neuromyelitis optica spectrum disorder (NMOSD) is a complement-mediated autoimmune disease in which unpredictable and relapsing attacks on the central nervous system cause irreversib
Externí odkaz:
https://doaj.org/article/8aae6e477a6f451e84e0e1f1a4138a6b
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Patients with neuromyelitis optica spectrum disorder (NMOSD) coexisting with both Sjögren’s syndrome (SS) and pancytopenia are exceptionally rare. There is no study on the treatment of such patients. We presented a case of AQP4-IgG seropositive re
Externí odkaz:
https://doaj.org/article/00a471f703eb45289a4f93fc68151709
Autor:
Benjamin Osborne, Gabriela Romanow, J. Michael Hemphill, Myassar Zarif, Tracy DeAngelis, Tyler Kaplan, Unsong Oh, Johnathan Pinkhasov, Kristina Patterson, Michael Levy
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder of the central nervous system characterized by recurrent, disabling attacks that affect the optic nerve, spinal cord, and brain/brainstem. While rituximab, targeting CD20-po
Externí odkaz:
https://doaj.org/article/84b6f2c74d1442d18eba9046a2c6517c
Autor:
Cory Perugino, Emma L. Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della-Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Löhr, Nicolas Schleinitz, Judith Falloon, Dewei She, Daniel Cimbora, John H. Stone
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1795-1808 (2023)
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a debilitating multiorgan disease characterized by recurring flares leading to organ dysfunction, decreased quality of life, and mortality. Glucocorticoids, the standard of care for
Externí odkaz:
https://doaj.org/article/8fd489c2c4564ecf821166afa716dc2e
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Neuromyelitis optica spectrum disorder (NMOSD) is a rare demyelinating disease of the central nervous system primarily affecting the optic nerves, spinal cord, and brainstem. Viral infection may trigger NMOSD. Here, we report the case of a 34-year-ol
Externí odkaz:
https://doaj.org/article/55560224efd447f296d0c68c22139cab
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundNeuromyelitis optica spectrum disorder (NMOSD) is a devastating inflammatory disease of the central nervous system that is often severely disabling from the outset. The lack of pathognomonic aquaporin 4 (AQP4) antibodies in seronegative NMO
Externí odkaz:
https://doaj.org/article/c1351b18489846df877cbdae443511c3
Publikováno v:
Frontiers in Ophthalmology, Vol 3 (2023)
Neuromyelitis Optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system (CNS) where aquaporin-4 water channels are the antigenic target of the disease. The spectrum of the disease involves regions of the CNS whe
Externí odkaz:
https://doaj.org/article/e8bb412f01c748929f99e420c515dda6
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 10, Pp 325-331 (2021)
Michael Levy,1 Maureen A Mealy2 1Department of Neurology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA; 2Medical Affairs, Horizon Therapeutics, Deerfield, IL, USACorrespondence: Michael LevyMassachusetts General Hospital &
Externí odkaz:
https://doaj.org/article/91e3f236142646969dd8fb29083de6db
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.